Stocktoria
CVS HEALTH Corp CVS
CVS HEALTH Corp financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $402.1B | $372.8B | $357.8B | $322.5B | $292.1B | $268.7B | $256.8B | $194.6B | $184.8B | $177.5B |
| Gross profit | — | — | — | — | — | — | — | — | $28.5B | $28.9B |
| Operating income | $4.7B | $8.5B | $13.7B | $8.0B | $13.3B | $13.9B | $12.0B | $4.0B | $9.5B | $10.4B |
| Interest expense | — | — | $2.7B | $2.3B | $2.5B | $2.9B | $3.0B | $2.6B | $1.1B | $1.1B |
| Income tax | $408.0M | $1.6B | $2.8B | $1.5B | $2.5B | $2.6B | $2.4B | $2.0B | $1.6B | $3.3B |
| Net income | $1.8B | $4.6B | $8.3B | $4.3B | $8.0B | $7.2B | $6.6B | -$594.0M | $6.6B | $5.3B |
| EPS (diluted) | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 | $5.46 | $5.08 | $-0.57 | $6.44 | $4.90 |
| Operating cash flow | $10.6B | $9.1B | $13.4B | $16.2B | $18.3B | $15.9B | $12.8B | $8.9B | $8.0B | $10.1B |
| Free cash flow | $7.8B | $6.3B | $10.4B | $13.4B | $15.7B | $13.4B | $10.4B | $6.8B | $6.1B | $7.9B |
| Cash & equivalents | $8.5B | $8.6B | $8.2B | $12.9B | $9.4B | $7.9B | $5.7B | $4.1B | $1.7B | $3.4B |
| Inventory | $19.2B | $18.1B | $18.0B | $19.1B | $17.8B | $18.5B | $17.5B | $16.4B | $15.3B | $14.8B |
| Total assets | $253.5B | $253.2B | $249.7B | $228.3B | $233.0B | $230.7B | $222.4B | $196.5B | $95.1B | $94.5B |
| Total liabilities | $178.2B | $177.5B | $173.1B | $156.5B | $157.6B | $161.0B | $158.3B | $137.9B | $57.4B | — |
| Shareholders' equity | $75.4B | $75.7B | $76.6B | $71.8B | $75.1B | $69.7B | $64.2B | $58.5B | $37.7B | $36.8B |
Growth · year-over-year · Revenue CAGR 9.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +7.8% | +4.2% | +10.9% | +10.4% | +8.7% | +4.6% | +32.0% | +5.3% | +4.1% | +15.8% |
| Net income growth | -61.7% | -44.7% | +93.6% | -46.1% | +11.5% | +8.2% | — | -109.0% | +24.5% | +1.5% |
| EPS growth | -62.0% | -43.4% | +98.5% | -45.8% | +10.3% | +7.5% | — | -108.9% | +31.4% | +5.8% |
| Free cash flow growth | +23.4% | -39.1% | -22.7% | -14.6% | +17.3% | +29.2% | +52.2% | +12.1% | -23.1% | +28.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.